Itonis Inc ITNS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $914,045.90
- Volume/Avg
- 400,500 / 7.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- http://www.itonisholdings.com
Valuation
|
Metric
|
ITNS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ITNS
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.24 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
ITNS
|
|---|---|
Return on Assets (Normalized) | −411.76% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Tfgdrngmw | Mpgzyt | $69.9 Bil | |
COR
| Cencora Inc | Ywgvzfw | Txjygf | $47.4 Bil | |
CAH
| Cardinal Health Inc | Wpdnvxfj | Xnbszn | $25.2 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Vpkrl | $8.6 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Xgkvxj | $8.6 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Nvyzwhl | $8.2 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Dpphk | $8.1 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Qpqydl | $7.6 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Mqsq | $3.3 Bil | |
MEPDF
| Medipal Holdings Corp | — | Tpcs | $3.3 Bil |